| Model Number |
EVOLUTPRO-26-US |
| Medical Device Problem Codes |
Perivalvular Leak (1457); Device Stenosis (4066)
|
| Health Effect - Clinical Codes |
Aortic Valve Stenosis (1717); Aortic Valve Insufficiency/ Regurgitation (4450)
|
| Date of Event |
06/10/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that following the implant of this transcatheter aortic bioprosthetic valve (tav), mild paravalvular leak was noted.Approximately 6 years, 10 months following valve implant, valve failure was reported.The primary mode of valve failure was structural valve deterioration: predominant aortic stenosis without hemodynamic valve deterioration.The patient was enrolled in a clinical study with existing, baseline valve failure to determine whether a redo-tav replacement procedure was appropriate.No patient complications were reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|